Adjuvant pembrolizumab prolongs overall survival in renal cell carcinoma at high-risk of recurrence after nephrectomy. Can we do better than this?
作者信息
Ciccarese Chiara, Mollica Veronica, Marandino Laura, Palumbo Carlotta, Campi Riccardo, Amparore Daniele
机构信息
Medical Oncology Unit, Department of Medical and Surgical Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.
Medical Oncology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy -
出版信息
Minerva Urol Nephrol. 2024 Oct;76(5):540-544. doi: 10.23736/S2724-6051.24.06114-7.
Abstract
摘要
Zotero 插件